{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:33:51Z","timestamp":1784194431501,"version":"3.55.0"},"reference-count":39,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":323,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Transplantation"],"published-print":{"date-parts":[[2001,2]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold>Because of the severe complications that may result from varicella zoster virus (VZV) infection following renal transplantation (Tx), transplanted varicella\u2010susceptible children exposed to varicella are typically given varicella zoster immunoglobulin (VZIG) as prophylaxis or are admitted and treated with parenteral acyclovir if VZIG prophylaxis fails. As both VZIG and hospitalization are costly, prevention of varicella infection by vaccination could potentially result in significant cost savings in addition to decreasing morbidity and mortality. To test this hypothesis, we developed a decision\u2010analysis model to evaluate the cost\u2010effectiveness of vaccinating patients with chronic renal failure (CRF) against varicella prior to renal transplant. Under baseline assumptions, vaccination for varicella pretransplant was a cost\u2010effective strategy, with a cost of $211 per patient vaccinated compared with $1,828 per patient not vaccinated. The magnitude of cost savings from vaccination was sensitive to variations in the cost of varicella vaccine, the percentage of patients hospitalized for treatment with acyclovir, and the percentage of patients exposed to varicella infection. One\u2010 and two\u2010way sensitivity analyses confirmed that vaccination was the dominant cost\u2010effective strategy under all conditions examined. We conclude that vaccination for varicella pretransplant is cost\u2010effective for patients with CRF, and that the magnitude of cost savings is sensitive to the cost of hospitalization, the percentage of patients exposed to varicella, and the cost of varicella vaccination. Pending results of ongoing studies of the safety and efficacy of VZV vaccine in children with CRF, we recommend that VZV vaccine be given to all children with CRF.<\/jats:p>","DOI":"10.1034\/j.1399-3046.2001.00032.x","type":"journal-article","created":{"date-parts":[[2003,5,16]],"date-time":"2003-05-16T15:32:07Z","timestamp":1053099127000},"page":"44-50","source":"Crossref","is-referenced-by-count":37,"title":["Pretransplant varicella vaccination is cost\u2010effective in pediatric renal transplantation"],"prefix":"10.1034","volume":"5","author":[{"given":"Allan D.","family":"Olson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Shope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1980.01380060049012"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198404000-00010"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(86)92981-6"},{"key":"e_1_2_6_5_2","first-page":"242","article-title":"Chickenpox in adult renal transplant recipients","volume":"1","author":"Bradley JR","year":"1987","journal-title":"Nephrol Dial Trans-plant"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/oxfordjournals.ndt.a092088","article-title":"Fatal varicella or Reye's syndrome: an unusual cause of death in a renal graft recipient","volume":"7","author":"Leguen E","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1542\/peds.90.2.216","article-title":"Varicella in pediatric renal transplant recipients","volume":"90","author":"Lynfield R","year":"1992","journal-title":"Pediatrics"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247197"},{"key":"e_1_2_6_9_2","first-page":"2512","article-title":"Fulminant hepatitis revealing primary vari\u2010ella in a renal graft recipient","volume":"27","author":"Bensousan TA","year":"1995","journal-title":"Transplant Proc"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.99.1.35"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70036-2"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199907150-00030"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.5.1291"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1399-0012.1995.tb00308.x","article-title":"Primary varicella in adult renal transplant recipients: a report of three cases plus a review of the literature","volume":"9","author":"Parnham AP","year":"1995","journal-title":"Clin Transpl"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1399-0012.1995.tb00332.x","article-title":"New strategies for the control of viral infection in organ transplantation","volume":"9","author":"Tolkoff\u2010Rubin NE","year":"1995","journal-title":"Clin Transpl"},{"key":"e_1_2_6_16_2","first-page":"573","volume-title":"1997 Red Book: Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics.","year":"1997"},{"key":"e_1_2_6_17_2","first-page":"3296","article-title":"Varicella Zoster in a transplant program: experience with 15 cases and 70 contacts","volume":"28","author":"Zayas E","year":"1996","journal-title":"Transplant Proc"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_B.169"},{"key":"e_1_2_6_19_2","first-page":"1926","article-title":"Safe use of acyclovir (Zovirax) in renal transplant patients on cyclosporine A therapy: Case reports","volume":"24","author":"Hayes K","year":"1992","journal-title":"Trans-plant Proc"},{"key":"e_1_2_6_20_2","first-page":"37","article-title":"Varicella in the first year after renal transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)","volume":"1","author":"Furth SL","year":"1997","journal-title":"Pediatr Transpl"},{"key":"e_1_2_6_21_2","first-page":"S87","article-title":"Immunizations for pediatric transplant patients","volume":"43","author":"Gershon AA","year":"1993","journal-title":"Kidney Int"},{"issue":"4","key":"e_1_2_6_22_2","first-page":"103","article-title":"Varicella vaccine in children with chronic renal insufficiency","volume":"61","author":"Broyer M","year":"1985","journal-title":"Postgrad Med J"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00865476"},{"key":"e_1_2_6_24_2","first-page":"1055","article-title":"Varicella vaccine in children requiring renal or hepatic transplantation","volume":"60","author":"Giacchino R","year":"1995","journal-title":"Transplantation"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004670050313"},{"key":"e_1_2_6_26_2","first-page":"164A","article-title":"One year follow\u2010up of Varivax\u00ae in children and adolescents with chronic renal insufficiency (CRI): a report of the South\u2010west Pediatric Nephrology Study Group","volume":"10","author":"Furth SL","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_6_27_2","first-page":"256","article-title":"Immunization guidelines for ped\u2010iatric renal disease","volume":"18","author":"Fivush BA","year":"1998","journal-title":"Semin Nephrol"},{"key":"e_1_2_6_28_2","first-page":"1","article-title":"Prevention of Varicella: Updated recommendations of the Ad\u2010visory Committee on Immunization Practices (ACIP)","volume":"48","author":"Centers for Disease Control and Prevention.","year":"1999","journal-title":"Morbid Mortal Wkly Rep"},{"key":"e_1_2_6_29_2","first-page":"750","article-title":"Age\u2010specific incidence of chickenpox","volume":"109","author":"Finger R","year":"1994","journal-title":"Public Health Rep"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a117238"},{"key":"e_1_2_6_31_2","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1542\/peds.70.4.604","article-title":"Varicella zoster in hospital personnel: skin test reactivity to monitor susceptibility","volume":"70","author":"Steele RW","year":"1982","journal-title":"Pediatrics"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198405313102201"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806113382407"},{"key":"e_1_2_6_34_2","first-page":"292","article-title":"Influence of immunosuppressive therapy on infectious complications in renal transplant recipients","volume":"24","author":"Klauser R","year":"1992","journal-title":"Transplant Proc"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-9942-2_9"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-0705-1_10"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/17.3.441"},{"key":"e_1_2_6_38_2","first-page":"791","article-title":"Recommendations for the use of live attunated varicella vaccine","volume":"95","author":"American Academy of Pediatrics Committee on Infectious Diseases.","year":"1995","journal-title":"Pediatrics"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.1.136"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1978.tb16280.x"}],"container-title":["Pediatric Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-3046.2001.00032.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1399-3046.2001.00032.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T10:26:27Z","timestamp":1733567187000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1399-3046.2001.00032.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["10.1034\/j.1399-3046.2001.00032.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1399-3046.2001.00032.x","archive":["Portico"],"relation":{},"ISSN":["1397-3142","1399-3046"],"issn-type":[{"value":"1397-3142","type":"print"},{"value":"1399-3046","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2]]}}}